BSECompany Update13 Oct 2026 · 13 Oct 2026, 05:11 pm

Compliance - certificate under Reg. 74(5) of SEBI (DP) Regulations 2018

Sangam Health Care Products Ltd · 531625

✦ AI SummaryRegulatory

Sangam Health Care Products Ltd has provided a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.09.2026, confirming that securities received for dematerialization have been verified and listed on the stock exchange.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sangam Health Care Products Ltd - 531625 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

f7ddcd12-4948-48e3-aa7b-8183f9a16b26.pdf

pdf

Download →
View document text
m' SANGAM HEALTHCARE PRODUCTS LTD. Safti (ISO Certified Company) (CIN: L24230TG1993PLC016731) To Date: 13.10.2026 BSE Limited P. J. Towers, Dalal Street, Mumbai — 400001. Dear Sir/ Madam, Sub: Compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended 30.09.2026. Ref: Sangam Health Care Products Ltd (BSE Scrip Code: 531625) Based on the certificate received from M/s. XL Softech Systems Limited, Registrar and Transfer Agent of the Company, we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted In our records as the registered owner within the stipulated time of receipt of the certificate of security. Further, we hereby certify that the securities which were dematerialized are listed on the Stock Exchange where the earlier issued securities are listed. This is for the information and records of the Exchange, please. Thanking you. Yours truly, For Sangam Health Care Products Limited D. Bhagat Reddy Managing Director DIN: (07087331) Encl: Copy to: Central Depository Services (India) Limited. National Securities Depository Limited Survey No:-182 Yellampet Village, Medchal Mandal, Medchal Malkangiri Dist, Telangana -501 401 INDIA. Email:marketing.sangam@gmail.com www.sangamhealthcare.co.in Phone.: +91- 7995066606 Date: 03.10.2026 The Company Secretary, Sangam Healthcare Products Limited. Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of india (Depositories and Participants) Regulations, 2018. Reference: NSDL/CIR/II/5/2019 dated 25th January, 2019. CDSL/OPS/RTA/POLCY/2019/14 dated 25th January, 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24th January, 2019 Dear Sir/Madam, In reference to the above captioned regulation, We hereby confirm that the securities received from the depository participants for dematerialization during the quarter ended 30th September, 2026 were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchange where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialization have been mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as the registered owner within 30 days. We request you to kindly take note of the above in your records. Thanking You, Yours faithfully, For XL Softech Systems Limited Authorised Signatory